CA1225594A - Methode pour l'administration percutanee d'agents actifs - Google Patents
Methode pour l'administration percutanee d'agents actifsInfo
- Publication number
- CA1225594A CA1225594A CA000452790A CA452790A CA1225594A CA 1225594 A CA1225594 A CA 1225594A CA 000452790 A CA000452790 A CA 000452790A CA 452790 A CA452790 A CA 452790A CA 1225594 A CA1225594 A CA 1225594A
- Authority
- CA
- Canada
- Prior art keywords
- carbon atoms
- alkyl group
- component
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49673283A | 1983-05-20 | 1983-05-20 | |
US496,732 | 1983-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1225594A true CA1225594A (fr) | 1987-08-18 |
Family
ID=23973888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000452790A Expired CA1225594A (fr) | 1983-05-20 | 1984-04-25 | Methode pour l'administration percutanee d'agents actifs |
Country Status (8)
Country | Link |
---|---|
CA (1) | CA1225594A (fr) |
CH (1) | CH657531A5 (fr) |
DE (1) | DE3418565C2 (fr) |
DK (1) | DK239984A (fr) |
FR (1) | FR2547503B1 (fr) |
GB (1) | GB2141025B (fr) |
NL (1) | NL8401422A (fr) |
SE (1) | SE8402561L (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4637930A (en) * | 1984-02-08 | 1987-01-20 | Yamanouchi Pharmaceutical Co, Ltd. | Transdermal formulation of nicardipine hydrochloride |
JPS61280426A (ja) * | 1985-06-04 | 1986-12-11 | Ikeda Mohandou:Kk | 消炎鎮痛用貼付剤 |
US4826686A (en) * | 1985-12-14 | 1989-05-02 | Boehringer Ingelheim Kg | Therapeutic system |
CH666621A5 (de) * | 1986-06-27 | 1988-08-15 | Ciba Geigy Ag | Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung. |
US4861764A (en) * | 1986-11-17 | 1989-08-29 | Macro Chem. Corp. | Percutaneous absorption enhancers, compositions containing same and method of use |
GB8718886D0 (en) * | 1987-08-10 | 1987-09-16 | Ici America Inc | Composition |
CA1334646C (fr) * | 1988-04-08 | 1995-03-07 | James Vanolden Peck | Produits stimulant la penetration transdermique |
US5246949A (en) * | 1989-12-06 | 1993-09-21 | Sansho Co., Ltd. | Preparation for endermism containing dopamine derivatives |
JPH03236317A (ja) * | 1989-12-06 | 1991-10-22 | Sansei Seiyaku Kk | ドパミン誘導体含有経皮用製剤 |
AU6410494A (en) * | 1993-03-17 | 1994-10-11 | Alza Corporation | Device for the transdermal administration of alprazolam |
DE4432429A1 (de) * | 1994-09-12 | 1996-03-14 | Heinz Prahm | Arzneimittel enthaltend S-Milchsäure und dessen Verwendung |
US5693335A (en) * | 1995-06-07 | 1997-12-02 | Cygnus, Inc. | Skin permeation enhancer composition for use with sex steroids |
DE19949202A1 (de) * | 1999-10-13 | 2001-05-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure |
JP2009509675A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 新規薬学的ビヒクルを用いる経皮薬剤送達システム、装置、及び方法 |
US7848801B2 (en) | 2005-12-30 | 2010-12-07 | Tti Ellebeau, Inc. | Iontophoretic systems, devices, and methods of delivery of active agents to biological interface |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1158283A (en) * | 1965-10-21 | 1969-07-16 | Foster Milburn Company | Composition to be Applied to Skin and Process for Preparing Same. |
FR2001768A1 (fr) * | 1968-02-12 | 1969-10-03 | Gillette Co | Compositions pour l'application topique de medicaments sur la peau |
SE325667B (fr) * | 1968-03-06 | 1970-07-06 | Medisan Ab | |
US3472931A (en) * | 1969-01-17 | 1969-10-14 | Foster Milburn Co | Percutaneous absorption with lower alkyl amides |
GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
GB1504302A (en) * | 1974-08-23 | 1978-03-15 | Fisons Ltd | Sedative method and composition |
US3957994A (en) * | 1974-12-19 | 1976-05-18 | Nelson Research & Development Company | Topical anti-inflammatory composition and method of use |
US3932653A (en) * | 1974-12-19 | 1976-01-13 | Nelson Research & Development Co. | Composition and method for topical administration of griseofulvin |
US4017641A (en) * | 1975-01-31 | 1977-04-12 | The Procter & Gamble Company | Skin moisturizing compositions containing 2-pyrrolidinone |
GB1538903A (en) * | 1975-04-11 | 1979-01-24 | Nelson Res & Dev | Carrier for a topically applied physiologically active agent or cosmetic agent |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4038417A (en) * | 1975-06-19 | 1977-07-26 | Nelson Research & Development Company | Method for treatment of psoriasis |
CA1165240A (fr) * | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Composes pharmaceutiques a usage topique |
FR2502951B1 (fr) * | 1981-04-06 | 1985-12-06 | Sandoz Sa | Compositions pharmaceutiques topiques sous forme d'une micro-emulsion |
-
1984
- 1984-04-25 CA CA000452790A patent/CA1225594A/fr not_active Expired
- 1984-05-04 NL NL8401422A patent/NL8401422A/nl not_active Application Discontinuation
- 1984-05-11 SE SE8402561A patent/SE8402561L/ not_active Application Discontinuation
- 1984-05-15 DK DK239984A patent/DK239984A/da not_active Application Discontinuation
- 1984-05-17 GB GB08412569A patent/GB2141025B/en not_active Expired
- 1984-05-18 DE DE19843418565 patent/DE3418565C2/de not_active Expired
- 1984-05-18 FR FR8407796A patent/FR2547503B1/fr not_active Expired
- 1984-05-18 CH CH245984A patent/CH657531A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK239984D0 (da) | 1984-05-15 |
FR2547503A1 (fr) | 1984-12-21 |
DE3418565C2 (de) | 1992-05-27 |
GB2141025A (en) | 1984-12-12 |
DE3418565A1 (de) | 1984-11-22 |
FR2547503B1 (fr) | 1987-11-20 |
SE8402561D0 (sv) | 1984-05-11 |
GB8412569D0 (en) | 1984-06-20 |
CH657531A5 (de) | 1986-09-15 |
NL8401422A (nl) | 1984-12-17 |
SE8402561L (sv) | 1984-11-21 |
DK239984A (da) | 1984-11-21 |
GB2141025B (en) | 1986-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4710497A (en) | Method for percutaneously administering physiologically active agents | |
CA1228027A (fr) | Methode d'administration percutanee d'agents ayant une action physiologique ayant recours a un alcool comme adjuvant et a un solvant | |
CA1225594A (fr) | Methode pour l'administration percutanee d'agents actifs | |
US4752612A (en) | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent | |
US4605670A (en) | Method for percutaneously administering metoclopramide | |
JPH0570610B2 (fr) | ||
KR20000049125A (ko) | 외용 국소 마취제 | |
US5128376A (en) | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator | |
JP3471840B2 (ja) | 外用剤 | |
CA1227753A (fr) | Methode pour l'administration percutanee d'agents ayant une action physiologique, ayant recours a un adjuvant, un solvant et un moderateur diol | |
JPS60228423A (ja) | 基剤組成物および外用医薬組成物 | |
JP2648960B2 (ja) | 外用医薬組成物 | |
US5183665A (en) | Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same | |
JPH05229949A (ja) | サリチル酸配合製剤 | |
JPH01207246A (ja) | 外用製剤用基剤組成物及び外用医薬組成物 | |
JPS61249934A (ja) | 外皮投与用組成物 | |
JPS5995212A (ja) | 基剤組成物及び外用医薬組成物 | |
JPS6287528A (ja) | N−アルキルモルホリン含有外皮投与用組成物 | |
JP3325039B2 (ja) | 皮膚刺激緩和組成物およびこれを含有する経皮外用剤 | |
JPS62187415A (ja) | 経皮吸収促進用組成物 | |
JPH06184000A (ja) | (−)−イソプレゴールからなる経皮吸収促進剤 | |
JPH11199485A (ja) | 抗真菌持続性外用剤 | |
JPS60243015A (ja) | 塩酸ニカルジピンの外用剤 | |
JPH08143474A (ja) | 経皮吸収促進剤 | |
JPH0570611B2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |